Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae

Abstract Background Oral beta-lactam antimicrobials are not routinely tested against Streptococcus pneumoniae due to presumed susceptibility based upon penicillin minimum inhibitory concentration (MIC) testing. Currently, Clinical and Laboratory Standards Institute provides comments to use penicilli...

詳細記述

書誌詳細

主要な著者:	Mark E. Murphy, Eleanor Powell, Joshua Courter, Joel E. Mortensen
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2021-07-01
シリーズ:	BMC Infectious Diseases
主題:	Streptococcus pneumoniae Susceptibility testing; pneumococcus Beta-lactams (β-lactams) Cefdinir
オンライン･アクセス:	https://doi.org/10.1186/s12879-021-06341-y
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!